{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:13:49Z","timestamp":1791645229774,"version":"4.3.4"},"reference-count":37,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"IIT clinical project, The First Affiliated Hospital, School of Medicine, Zhejiang University","award":["BL202221"],"award-info":[{"award-number":["BL202221"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Vascular"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate the one-year results of the Eluvia drug-eluting vascular stent (Boston Scientific, Marlborough, MA, USA) for the treatment of femoropopliteal occlusive disease (FPOD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From January 2021 to November 2023, this multicenter study prospectively enrolled patients with peripheral artery disease involving the femoropopliteal artery. The primary outcome measures were the rate of freedom from clinically driven target limb revascularization (f-CD-TLR), rate of freedom from major adverse events (f-MAE), rate of freedom from symptom recurrence (f-SR) and rate of freedom from all-cause death (f-ACD). The secondary outcome measures were the Rutherford grade and Vascular Quality of Life (VascuQoL) scale scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 159 patients were enrolled in this study. The mean follow-up time was 370 days, and the follow-up rate was 83.0%. The patients\u2019 mean age was 72 years, and 82.4% were male. A total of 159 patients received 199 stent deployments. The mean lesion length was 194.4 \u00b1 118.9\u00a0mm, and 76.7% had total occlusions. The technical success rate for endovascular treatment was 100%, and five complications occurred during the perioperative period. At one, three, six, and 12 months, the f-CD-TLR rate was 99.3%, 97.9%, 96.4%, and 92.8%, respectively; the f-MAE rate was 98.0%, 96.7%, 93.1%, and 91.3%, respectively; the f-SR rate was 94.6%, 85.5%, 80.3%, and 73.4%, respectively; and the f-ACD rate was 98.0%, 98.0%, 95.9% and 94.1%, respectively. There was a substantial increase in the Rutherford grade and average VascuQoL scores at the one-, three-, six-, and 12-month follow-ups (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; .001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The Eluvia stent had a favorable effect on FPOD throughout 12 months of follow-up. Further studies with larger sample sizes and longer-term follow-up are required to confirm the real-world performance of the Eluvia stent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17085381251342326","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:32:48Z","timestamp":1747157568000},"page":"472-481","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Eluvia stent in endovascular treatment of femoropopliteal occlusive disease: Early results of the challenge study"],"prefix":"10.1177","volume":"34","author":[{"given":"Yiting","family":"Xu","sequence":"first","affiliation":[{"name":"Zhejiang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[{"name":"Zhejiang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-9263","authenticated-orcid":false,"given":"Chenyang","family":"Qiu","sequence":"additional","affiliation":[{"name":"Zhejiang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Qingdao University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ye","sequence":"additional","affiliation":[{"name":"Shanghai Jiaotong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9150-5674","authenticated-orcid":false,"given":"Zhenyu","family":"Shi","sequence":"additional","affiliation":[{"name":"Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4049-547X","authenticated-orcid":false,"given":"Xin","family":"Fang","sequence":"additional","affiliation":[{"name":"Zhejiang University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4812-7353","authenticated-orcid":false,"given":"Chunshui","family":"He","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of TCM"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibo","family":"Feng","sequence":"additional","affiliation":[{"name":"Liyuan Hospital of Tongji Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Sang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Soochow University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3552-160X","authenticated-orcid":false,"given":"Lianrui","family":"Guo","sequence":"additional","affiliation":[{"name":"Xuanwu Hospital"},{"name":"Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8960-9733","authenticated-orcid":false,"given":"Ziheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Zhejiang University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001005"},{"key":"e_1_3_7_3_2","volume-title":"National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis","author":"Song P","year":"2019","unstructured":"Song P, Rudan D, Wang M, et al. National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis. The University of Edinburgh; 2019, vol 9."},{"key":"e_1_3_7_4_2","volume-title":"mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO)","author":"Ricco JB","year":"2018","unstructured":"Ricco JB, Bartelink MLEL. Document covering atherosclerotic disease of extracranial carotid and vertebral. mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO), 2018."},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/1526602820938465"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.09.039"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.05.034"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2007.07.059"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X20987894"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059606"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/1526602819895996"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-019-02332-4"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.016900"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1230098"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32262-1"},{"key":"e_1_3_7_16_2","doi-asserted-by":"crossref","unstructured":"Stavroulakis K. 2-Year outcomes of the Eluvia drug-eluting stent for the treatment of complex femoropopliteal lesions 2021; 14.","DOI":"10.1016\/j.jcin.2021.01.026"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-021-02901-6"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.10.047"},{"key":"e_1_3_7_19_2","volume":"7","author":"Song P","year":"2019","unstructured":"Song P. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: An Updated Systematic Review and Analysis 2019; 7.","journal-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: An Updated Systematic Review and Analysis"},{"key":"e_1_3_7_20_2","first-page":"274","article-title":"Chinese version visual vascular quality of life questionnaire for evaluating life quality of patients with peripheral artery disease in China","volume":"20","author":"Zhu J","year":"2023","unstructured":"Zhu J, Lau JY, Yu CM, et al. Chinese version visual vascular quality of life questionnaire for evaluating life quality of patients with peripheral artery disease in China. Chin J Interventional Imaging Ther 2023; 20: 274\u2013277.","journal-title":"Chin J Interventional Imaging Ther"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2008.06.020"},{"key":"e_1_3_7_22_2","unstructured":"Rabin REQSD. A measure of health status from the EuroQol Group. Ann Med."},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semvascsurg.2022.04.010"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2021.101082"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/15266028211049339"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2019.12.028"},{"key":"e_1_3_7_27_2","unstructured":"Vent PA Bare metal versus paclitaxel eluting stents for long femoropopliteal lesions: prospective cohorts comparison using a propensity-score matched analysis."},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/1526602816650206"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/1526602820901723"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-019-02355-x"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028425"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/1526602815610118"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.5551\/jat.50369"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2022.2088965"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001251"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2023.03.042"},{"key":"e_1_3_7_37_2","first-page":"21","article-title":"Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: a subanalysis of the COMPASS randomized clinical trial","volume":"6","author":"Kaplovitch E","year":"2021","unstructured":"Kaplovitch E, Eikelboom JW, Dyal L, et al. Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: a subanalysis of the COMPASS randomized clinical trial. JAMA Cardiol 2021; 6: 21\u201329.","journal-title":"JAMA Cardiol"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709118"}],"container-title":["Vascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17085381251342326","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17085381251342326","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17085381251342326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:41:21Z","timestamp":1777707681000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17085381251342326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1177\/17085381251342326"],"URL":"https:\/\/doi.org\/10.1177\/17085381251342326","relation":{},"ISSN":["1708-5381","1708-539X"],"issn-type":[{"value":"1708-5381","type":"print"},{"value":"1708-539X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]}}}